{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:36:29Z","timestamp":1794778589521,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/s0306-4530(03)00096-9","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T21:24:25Z","timestamp":1059686665000},"page":"39-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"S3","title":["A review of treatment of premenstrual syndrome &amp; premenstrual dysphoric disorder"],"prefix":"10.1016","volume":"28","author":[{"given":"Andrea","family":"Rapkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0306-4530(03)00096-9_BIB1","unstructured":"ACOG (American College of Obstetricians and Gynecologists), 2000. Premenstrual Syndrome. ACOG Practice Bulletin No. 15, April."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB2","unstructured":"APA (American Psychiatric Association), 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. (DSM-IV). American Psychiatric Association, Washington, DC, pp. 715-718."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-3223(88)90277-6","article-title":"Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual synrome","volume":"24","author":"Ashby","year":"1988","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB4","first-page":"120","article-title":"Spironolactone in the treatment of premenstrual tension: A double-blind study of spironolactone versus bendrflumehtiazide and placebo","volume":"49","author":"Aslaksen","year":"1991","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(92)90006-F","article-title":"Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations","volume":"46","author":"B\u00e4ckstr\u00f6m","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1523\/JNEUROSCI.02-02-00199.1982","article-title":"Modulation by estradiol of serotonin receptors in brain","volume":"2","author":"Biegon","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3999(98)00042-7","article-title":"Cognitive therapy for premenstrual syndrome: A controlled trial","volume":"45","author":"Blake","year":"1998","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB8","first-page":"779","article-title":"Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial","volume":"84","author":"Brown","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9378(90)90831-Q","article-title":"The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome","volume":"162","author":"Casper","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-0327(94)00073-I","article-title":"The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes","volume":"33","author":"Christensen","year":"1995","journal-title":"J. Affect. Disor."},{"issue":"2","key":"10.1016\/S0306-4530(03)00096-9_BIB11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0015-0282(00)01707-6","article-title":"Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome","volume":"75","author":"Di Carlo","year":"2001","journal-title":"Fertil. Steril."},{"issue":"9236","key":"10.1016\/S0306-4530(03)00096-9_BIB12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02754-9","article-title":"Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review","volume":"356","author":"Dimmock","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0031-9384(97)88991-3","article-title":"The influence of menstrual-cycle phase on the relationship between testosterone and aggression","volume":"62","author":"Dougherty","year":"1997","journal-title":"Physiol. Behav."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0893-133X(94)00076-C","article-title":"The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome","volume":"12","author":"Eriksson","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","article-title":"Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls","volume":"17","author":"Eriksson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB16","first-page":"177","article-title":"Oral magnesium successfully relieves premenstrual mood changes","volume":"78","author":"Facchinetti","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB17","first-page":"7","article-title":"Sertraline versus desipramine in the treatment of premenstrual syndrome: An open-label trial","volume":"57","author":"Freeman","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1995.03530010065036","article-title":"A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome","volume":"274","author":"Freeman","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB19","first-page":"192","article-title":"Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: A pilot study","volume":"54","author":"Freeman","year":"1993","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J. Womens Health Gend. Based Med."},{"issue":"5","key":"10.1016\/S0306-4530(03)00096-9_BIB21","first-page":"737","article-title":"Venlafaxine in the treatment of premenstrual dysphoric disorder","volume":"98","author":"Freeman","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB23","first-page":"649","article-title":"Alleviation of premenstrual syndrome symptoms with the relaxation response","volume":"75","author":"Goodale","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0015-0282(16)54718-9","article-title":"Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes","volume":"56","author":"Halbreich","year":"1991","journal-title":"Fertil. Steril."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v58n0905","article-title":"Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome","volume":"58","author":"Halbreich","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.1990.01810150070011","article-title":"Treatment of premenstrual dysphoria with alprazolam. A controlled study","volume":"47","author":"Harrison","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archfami.8.4.328","article-title":"Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study","volume":"8","author":"Jermain","year":"1999","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1037\/0022-006X.62.5.1026","article-title":"Changes in premenstrual symptoms and irrational thinking following cognitive-behavioral coping skills training","volume":"62","author":"Kirkby","year":"1994","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB30","first-page":"400","article-title":"Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome","volume":"32","author":"London","year":"1987","journal-title":"J. Reprod. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00845105","article-title":"A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome","volume":"14","author":"Morse","year":"1991","journal-title":"J. Behav. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00003081-199309000-00032","article-title":"Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome","volume":"36","author":"Mortola","year":"1993","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB33","first-page":"302","article-title":"Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences","volume":"76","author":"Mortola","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB34","doi-asserted-by":"crossref","first-page":"252A","DOI":"10.1210\/jcem-72-2-252","article-title":"Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen\/progestin","volume":"72","author":"Mortola","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","article-title":"The premenstrual syndrome. Effects of \u201cmedical ovariectomy\u201d","volume":"311","author":"Muse","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB36","first-page":"141","article-title":"Treatment of premenstrual syndrome by spironolactone","volume":"86","author":"O\u2019Brien","year":"1979","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(99)70142-0","article-title":"Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol","volume":"180","author":"O\u2019Brien","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4088\/JCP.v61n0205","article-title":"Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with Sertraline or placebo","volume":"61","author":"Pearlstein","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB40","first-page":"332","article-title":"Long-term fluoxetine treatment of late luteal phase dysphoric disorder","volume":"55","author":"Pearlstein","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-199708000-00004","article-title":"Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder","volume":"17","author":"Pearlstein","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0015-0282(16)59045-1","article-title":"Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial","volume":"47","author":"Prior","year":"1987","journal-title":"Fertil. Steril."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00003081-199209000-00022","article-title":"The role of serotonin in premenstrual syndrome","volume":"35","author":"Rapkin","year":"1992","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2466\/pr0.1988.62.1.55","article-title":"Comparison of retrospective and prospective assessment of premenstrual symptoms","volume":"62","author":"Rapkin","year":"1988","journal-title":"Psychol. Rep."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB45","first-page":"533","article-title":"Whole-blood serotonin in premenstrual syndrome","volume":"70","author":"Rapkin","year":"1987","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/01443618709068522","article-title":"Premenstrual syndrome: a double blind placebo controlled study of treatment with progesterone vaginal suppositories","volume":"7","author":"Rapkin","year":"1987","journal-title":"J. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","article-title":"Progesterone metabolite allopregnanolone in women with premenstrual syndrome","volume":"90","author":"Rapkin","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(89)92591-9","article-title":"Buspirone in treatment of premenstrual syndrome [letter]","volume":"1","author":"Rickels","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9378(88)90765-X","article-title":"Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects","volume":"158","author":"Rubinow","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB50","first-page":"33","article-title":"Premenstrual syndrome: Beneficial effects of periodic, low-dose danazol","volume":"70","author":"Sarno","year":"1987","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0029-7844(95)00246-N","article-title":"The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome","volume":"86","author":"Sayegh","year":"1995","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-3999(93)90079-U","article-title":"The effects of aerobic exercise on premenstrual symptoms in middle-aged women: A preliminary study","volume":"37","author":"Steege","year":"1993","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00005-5","article-title":"A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria","volume":"45","author":"Steinberg","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB55","first-page":"771","article-title":"Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria","volume":"33","author":"Steiner","year":"1997","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB56","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","article-title":"Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine\/Premenstrual Dysphoria Collaborative Study Group","volume":"332","author":"Steiner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB57","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users, continuous use","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1993.52","article-title":"Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial","volume":"9","author":"Sundblad","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.1992.tb01440.x","article-title":"Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial","volume":"85","author":"Sundblad","year":"1992","journal-title":"Acta. Psychiatr. Scand."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02599520","article-title":"Calcium supplementation in premenstrual syndrome: A randomized crossover trial","volume":"4","author":"Thys-Jacobs","year":"1989","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB62","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(89)90784-8","article-title":"Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone","volume":"2","author":"Watson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199810000-00007","article-title":"Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?","volume":"18","author":"Wikander","year":"1998","journal-title":"J. Clin Psychopharmacol."},{"key":"10.1016\/S0306-4530(03)00096-9_BIB64","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review","volume":"318","author":"Wyatt","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB65","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1997.03550120043031","article-title":"Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group","volume":"278","author":"Yonkers","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0306-4530(03)00096-9_BIB66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4088\/JCP.v59n0206","article-title":"Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial","volume":"59","author":"Young","year":"1998","journal-title":"J. Clin. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453003000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453003000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:24:20Z","timestamp":1759681460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453003000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":66,"alternative-id":["S0306453003000969"],"URL":"https:\/\/doi.org\/10.1016\/s0306-4530(03)00096-9","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0306-4530(03)00096-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}